Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Undervaluation Of Vical's Full Pipeline Allows A Cheap Bet On Cancer Trial
Seeking Alpha
Friday, May 3, 2013 - 12:57pm
tags:
Vical, Amgen, Bristol-Myers Squibb, OncoSec, ImmunoCellular Therapeutics, Roche, NCT00395070, melanoma
Durect: Pfizer Hints At Progress With Remoxy
Seeking Alpha
Friday, May 3, 2013 - 12:55pm
tags:
Durect, Remoxy, Pfizer
Lilly broadens diabetes offer with eye on bigger slice of booming market
Reuters
Friday, May 3, 2013 - 12:53pm
tags:
diabetes, Eli Lilly
Johnson & Johnson: At The Crossroads
Seeking Alpha
Friday, May 3, 2013 - 12:52pm
tags:
JNJ
Teva Pharma 1st qtr profit sinks 27 percent as generic competition, other factors hurt revenue
Yahoo/AP
Friday, May 3, 2013 - 9:06am
tags:
Teva, earnings
Athersys Has Some Promise, But Controversy And Doubt Remain
Seeking Alpha
Friday, May 3, 2013 - 9:04am
tags:
Athersys, GSK, Osiris, Sanofi, Pfizer
Big drugmakers think small with nanomedicine deals
Reuters
Friday, May 3, 2013 - 9:03am
tags:
nanomedicine, nanoparticles, Amgen, Pfizer, AstraZeneca, Bind Therapeutics
Allergan's Juvederm Voluma unanimously recommended by FDA Advisory Committee
The Fly on the Wall
Friday, May 3, 2013 - 9:00am
tags:
FDA, advisory panels, Juvederm Voluma, Allergan
FDA advisers recommend against Delcath's cancer therapy
Reuters
Friday, May 3, 2013 - 8:59am
tags:
FDA, advisory panels, Delcath, Melblez
US judge gives onetime 'King of Biotech' 4 yrs in prison
Reuters
Friday, May 3, 2013 - 8:57am
tags:
biotech, David Blech, Pleuristem, Intellect Neurosciences, stock manipulation
Arena Falls, Pulls Anti-Obesity Application In Europe
Seeking Alpha
Friday, May 3, 2013 - 8:56am
tags:
Arena Pharmaceuticals, Europe, Belviq, earnings, Vivus
Gilead's HCV Drug Pipeline Outshines Weak Q1 Results
Investors.com
Friday, May 3, 2013 - 8:54am
tags:
earnings, Gilead, hepatitis C
Analysts drop Arena Pharma stock price targets as drugmaker withdraws Belviq application in EU
Yahoo/AP
Friday, May 3, 2013 - 8:53am
tags:
Belviq, Europe, Arena Pharmaceuticals
The Market's Got This Biotech All Wrong
Motley Fool
Friday, May 3, 2013 - 8:52am
tags:
Questcor, biotech, earnings
Regeneron acquires full rights to two novel development programs from Sanofi
Yahoo/Fly on the Wall
Friday, May 3, 2013 - 8:51am
tags:
Sanofi, Regeneron, ANG2, PDGF
The New Abbott Labs Is Leaner, but Needs Better Execution
TheStreet.com
Friday, May 3, 2013 - 8:49am
tags:
Abbott Laboratories, AbbVie, JNJ
Zogenix Poised For 40% Haircut As Zohydro Decision Approaches
Seeking Alpha
Friday, May 3, 2013 - 8:47am
tags:
Zogenix, Zohydro ER, painkillers
A.P. Pharma: Management Change Is A Positive For The Stock
Seeking Alpha
Friday, May 3, 2013 - 8:46am
tags:
AP Pharma
EPO Pills: A Challenge For Amgen And Johnson & Johnson
Seeking Alpha
Thursday, May 2, 2013 - 3:50pm
tags:
JNJ, Amgen, Aranesp, Procrit, Epogen
Elan considered buying Royalty before becoming its target
Reuters
Thursday, May 2, 2013 - 3:48pm
tags:
Elan, Royalty Pharma, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.